Posted by Michael Wonder on 17 May 2024
Health Canada approves Saladax’s 5-fluorouracil chemotherapy therapeutic drug monitoring test
14 May 2024 - Saladax Biomedical is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada in a rapid six days.
The Saladax My5-FU blood test, used in multiple countries worldwide, is now approved in Canada, the European Union, China, the United Kingdom, and Israel. The only major country where it is not approved is the United States.
